XTI Aerospace (NASDAQ: XTIA), a pioneer xVTOL and powered-lift aviation technologies, today announced that its wholly owned subsidiary, XTI Aircraft Company—the developer of the revolutionary TriFan ...

The antibody discovery market is expanding, driven by the increasing incidence of chronic conditions such as cancer, diabetes, and cardiovascular and neurological diseases. The adoption of biologics, ...